BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8583999)

  • 1. Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy.
    Fine HA
    Neurol Clin; 1995 Nov; 13(4):827-46. PubMed ID: 8583999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.
    Barzon L; Zanusso M; Colombo F; Palù G
    Cancer Gene Ther; 2006 Jun; 13(6):539-54. PubMed ID: 16410822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New frontiers in therapy of malignant gliomas.
    Puduvalli VK; Yung AW
    Forum (Genova); 1998; 8(3):261-9. PubMed ID: 9755291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
    Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
    Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing boundaries in the treatment of malignant gliomas.
    Brandes AA; Basso U; Pasetto LM
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment strategies for malignant gliomas.
    Avgeropoulos NG; Batchelor TT
    Oncologist; 1999; 4(3):209-24. PubMed ID: 10394589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies for malignant gliomas.
    Cavaliere R; Wen PY; Schiff D
    Neurol Clin; 2007 Nov; 25(4):1141-71, x. PubMed ID: 17964029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic principles of immunotherapy for malignant gliomas.
    Han SJ; Kaur G; Yang I; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):1-16. PubMed ID: 19944962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular control of the cellular cycle and apoptosis: new treatments for gliomas].
    Fueyo J; Gómez-Manzano C
    Neurologia; 1998; 13(7):349-55. PubMed ID: 9810797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.
    Argyriou AA; Antonacopoulou A; Iconomou G; Kalofonos HP
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):199-210. PubMed ID: 18602834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.